Robert Perry, MD
Gynecology · Rushville, INNPI 1992787246
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $833, more than ten times the $38 reported in 2019.
Across 148 payments — averaging $19.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$334
- AstraZeneca$294
- Merck$278
- Johnson & Johnson$224
- Bayer$207
- Eisai Inc.$162
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,933100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 19 | $334 |
| AstraZeneca(2 entities) | 15 | $294 |
| Merck | 14 | $278 |
| Johnson & Johnson | 8 | $224 |
| Bayer | 11 | $207 |
| Eisai Inc. | 8 | $162 |
| Incyte Corporation | 8 | $151 |
| Genentech USA, Inc. | 8 | $126 |
| Amgen | 6 | $99 |
| Daiichi Sankyo Inc. | 4 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $86 |
| Integra Lifesciences Corporation | 1 | $61 |
| Adaptive Biotechnologies Corporation | 3 | $60 |
| Jazz Pharmaceuticals Inc. | 2 | $57 |
| Sanofi | 2 | $51 |
| Tempus AI, Inc | 2 | $51 |
| Genmab U.S., Inc. | 3 | $49 |
| AbbVie | 2 | $49 |
| Exelixis Inc. | 3 | $47 |
| Geron Corporation | 2 | $44 |
| Hologic Sales And Service, LLC | 2 | $44 |
| Sobi, Inc | 3 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| Seagen Inc. | 2 | $37 |
| CTI Biopharma Corp. | 2 | $32 |
| Pharming Healthcare, Inc. | 1 | $28 |
| Coopersurgical, Inc. | 1 | $26 |
| Taiho Oncology, Inc. | 1 | $24 |
| Acrotech Biopharma Inc. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Syndax Pharmaceuticals, Inc. | 1 | $21 |
| Gilead | 1 | $19 |
| Pharmaessentia USA Corporation | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| GSK | 1 | $14 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$2,933 in reported general payments places this provider in the 75th percentile of 30 gynecology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 17 | $1,454 |
| Estradiol | 15 | $1,232 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Rushville
- Kevin MillerLafayette$15K
- Emily ClineWhiteland$12K
- Joel McCuaigWest Lafayette$4K
- Bryan PerkinsIndianapolis$4K
- Anthony IwuagwuGary$3K
- Pamela StoneGoshen$3K
- Michelle MurphyIndianapolis$3K
- Madalyn SquiresIndianapolis$2K
- Jill GreenJeffersonville$2K
- Landon HarrisonFort Wayne$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.